Search Results

There are 7618413 results for: content related to: Cetuximab in hemodialysis: A case report

  1. You have free access to this content
    Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer

    Intervention Review

    The Cochrane Library

    Zu-Yao Yang, Li Liu, Chen Mao, Xin-Yin Wu, Ya-Fang Huang, Xue-Feng Hu and Jin-Ling Tang

    Published Online : 17 NOV 2014, DOI: 10.1002/14651858.CD009948.pub2

  2. You have free access to this content
    Enhancement of tumor uptake and therapeutic efficacy of EGFR-targeted antibody cetuximab and antibody–drug conjugates by cholesterol sequestration

    International Journal of Cancer

    Volume 136, Issue 1, 1 January 2015, Pages: 182–194, Yang Chen, Guanghua Liu, Lifang Guo, Hui Wang, Yan Fu and Yongzhang Luo

    Version of Record online : 14 MAY 2014, DOI: 10.1002/ijc.28950

  3. Anti-EGFR Monoclonal Antibodies for Treatment of Colorectal Cancers: Development of Cetuximab and Panitumumab

    The Journal of Clinical Pharmacology

    Volume 52, Issue 2, February 2012, Pages: 128–155, Dr Benoit You and Dr Eric X. Chen

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010395940

  4. You have free access to this content
    Clinically Relevant Radioactive Dose Formulation of 177Lu-Labeled Cetuximab-Fab Fragment for Potential Use in Cancer Theranostics

    ChemistrySelect

    Volume 3, Issue 1, January 10, 2018, Pages: 242–248, Dr. Rubel Chakravarty, Nanda Rohra, Dr. Sudipta Chakraborty, Dr. Ratnesh Jain, Dr. Haladhar Dev Sarma and Dr. Ashutosh Dash

    Version of Record online : 3 JAN 2018, DOI: 10.1002/slct.201702224

  5. Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer

    Intervention Review

    The Cochrane Library

    David Lok Hang Chan, Eva Segelov, Rachel SH Wong, Annabel Smith, Rebecca A Herbertson, Bob T. Li, Niall Tebbutt, Timothy Price and Nick Pavlakis

    Published Online : 27 JUN 2017, DOI: 10.1002/14651858.CD007047.pub2

  6. You have full text access to this OnlineOpen article
    Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit

    Cancer Medicine

    Volume 4, Issue 1, January 2015, Pages: 65–74, Uma Raju, David P. Molkentine, David R. Valdecanas, Amit Deorukhkar, Kathryn A. Mason, Thomas A. Buchholz, Raymond E. Meyn, Kie-Kian Ang and Heath Skinner

    Version of Record online : 29 OCT 2014, DOI: 10.1002/cam4.345

  7. You have free access to this content
    Radiolabeled cetuximab: Dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model

    International Journal of Cancer

    Volume 129, Issue 4, 15 August 2011, Pages: 870–878, Bianca A.W. Hoeben, Janneke D.M. Molkenboer-Kuenen, Wim J.G. Oyen, Wenny J.M. Peeters, Johannes H.A.M. Kaanders, Johan Bussink and Otto C. Boerman

    Version of Record online : 1 DEC 2010, DOI: 10.1002/ijc.25727

  8. You have full text access to this Open Access content
    Antitumor activity of cetuximab against malignant glioma cells overexpressing EGFR deletion mutant variant III

    Cancer Science

    Volume 99, Issue 10, October 2008, Pages: 2062–2069, Junya Fukai, Kazuto Nishio, Toru Itakura and Fumiaki Koizumi

    Version of Record online : 3 OCT 2008, DOI: 10.1111/j.1349-7006.2008.00945.x

  9. The role of cetuximab as first-line treatment of colorectal liver metastases

    HPB

    Volume 15, Issue 1, January 2013, Pages: 11–17, Claire Jones, Mark A. Taylor and Billy McWilliams

    Version of Record online : 17 OCT 2012, DOI: 10.1111/j.1477-2574.2012.00591.x

  10. Utility of serum anti-cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab

    British Journal of Clinical Pharmacology

    Volume 83, Issue 3, March 2017, Pages: 623–631, Benoît Dupont, Delphine Mariotte, Audrey E. Dugué, Bénédicte Clarisse, Jean-Michel Grellard, Emmanuel Babin, Bruno Chauffert, Stéphanie Dakpé, Cristian Moldovan, Karine Bouhier-Leporrier, Jean-Marie Reimund, Frederic Di Fiore, Sylvie Zanetta, Audrey Mailliez, Pascal Do, Annie Peytier, Marie-Pierre Galais, Carmen Florescu, Roland Schott, Brigitte Le Mauff and Radj Gervais

    Version of Record online : 24 OCT 2016, DOI: 10.1111/bcp.13140

  11. Approval Summary: Cetuximab in Combination With Cisplatin or Carboplatin and 5-Fluorouracil for the First-Line Treatment of Patients With Recurrent Locoregional or Metastatic Squamous Cell Head and Neck Cancer

    The Oncologist

    Volume 18, Issue 4, April 2013, Pages: 460–466, Martin H. Cohen, Huanyu Chen, Stacy Shord, Chana Fuchs, Kun He, Hong Zhao, Sharon Sickafuse, Patricia Keegan and Richard Pazdur

    Version of Record online : 12 APR 2013, DOI: 10.1634/theoncologist.2012-0458

  12. You have full text access to this OnlineOpen article
    A novel approach to predict cetuximab-induced hypersensitivity reaction: detection of drug-specific IgE on basophils

    Cancer Medicine

    Volume 5, Issue 6, June 2016, Pages: 1004–1012, Takuya Iwamoto, Akiharu Okamoto, Hajime Ishinaga, Kasumi Shimizu, Alberto A. Gayle, Naoya Arai, Kazuhiko Takeuchi and Masahiro Okuda

    Version of Record online : 16 FEB 2016, DOI: 10.1002/cam4.658

  13. You have free access to this content
    Controversies in antiepidermal growth factor receptor therapy in metastatic colorectal cancer

    Cancer

    Volume 119, Issue 11, 1 June 2013, Pages: 1941–1950, Janghee Woo, Neil Palmisiano, William Tester and John C. Leighton Jr.

    Version of Record online : 15 MAR 2013, DOI: 10.1002/cncr.27994

  14. You have full text access to this OnlineOpen article
    A prospective trial comparing FDG-PET/CT and CT to assess tumor response to cetuximab in patients with incurable squamous cell carcinoma of the head and neck

    Cancer Medicine

    Volume 3, Issue 6, December 2014, Pages: 1493–1501, Douglas Adkins, Jessica Ley, Farrokh Dehdashti, Marilyn J. Siegel, Tanya M. Wildes, Loren Michel, Kathryn Trinkaus and Barry A. Siegel

    Version of Record online : 1 AUG 2014, DOI: 10.1002/cam4.294

  15. You have free access to this content
    Cetuximab induce antibody-dependent cellular cytotoxicity against EGFR-expressing esophageal squamous cell carcinoma

    International Journal of Cancer

    Volume 120, Issue 4, 15 February 2007, Pages: 781–787, Yoshihiko Kawaguchi, Koji Kono, Kousaku Mimura, Hidemitsu Sugai, Hidenori Akaike and Hideki Fujii

    Version of Record online : 9 NOV 2006, DOI: 10.1002/ijc.22370

  16. Cetuximab increases concentrations of irinotecan and of its active metabolite SN-38 in plasma and tumour of human colorectal carcinoma-bearing mice

    Fundamental & Clinical Pharmacology

    Volume 28, Issue 6, December 2014, Pages: 652–660, Céline Chu, Chadi Abbara, Mahamadou Tandia, Mélanie Polrot, Patrick Gonin, Robert Farinotti and Laurence Bonhomme-Faivre

    Version of Record online : 16 APR 2014, DOI: 10.1111/fcp.12071

  17. You have full text access to this Open Access content
    Gene status of head and neck squamous cell carcinoma cell lines and cetuximab-mediated biological activities

    Cancer Science

    Volume 102, Issue 9, September 2011, Pages: 1717–1723, Norio Kondo, Mamoru Tsukuda, Takahide Taguchi, Kouichi Nakazaki, Atsuko Sakakibara, Hideaki Takahashi, Gabor Toth and Goshi Nishimura

    Version of Record online : 3 JUL 2011, DOI: 10.1111/j.1349-7006.2011.01999.x

    Corrected by:

    Correction: Correction

    Vol. 105, Issue 11, 1518, Version of Record online: 20 NOV 2014

  18. You have full text access to this Open Access content
    Interleukin-2 potentiation of cetuximab antitumor activity for epidermal growth factor receptor-overexpressing gastric cancer xenografts through antibody-dependent cellular cytotoxicity

    Cancer Science

    Volume 99, Issue 7, July 2008, Pages: 1471–1478, Masayasu Hara, Hayao Nakanishi, Kunio Tsujimura, Makoto Matsui, Yasushi Yatabe, Tadao Manabe and Masae Tatematsu

    Version of Record online : 16 APR 2008, DOI: 10.1111/j.1349-7006.2008.00821.x

  19. 90Y/177Lu-labelled Cetuximab immunoconjugates: radiochemistry optimization to clinical dose formulation

    Journal of Labelled Compounds and Radiopharmaceuticals

    Volume 59, Issue 9, July 2016, Pages: 354–363, Rubel Chakravarty, Sudipta Chakraborty, Haladhar Dev Sarma, K. V. Vimalnath Nair, Ardhi Rajeswari and Ashutosh Dash

    Version of Record online : 5 JUN 2016, DOI: 10.1002/jlcr.3413

  20. Synergy Between Cetuximab and Chemotherapy in Tumors of the Gastrointestinal Tract

    The Oncologist

    Volume 13, Issue 1, January 2008, Pages: 39–50, Reshma L. Mahtani and John S. Macdonald

    Version of Record online : 1 JAN 2008, DOI: 10.1634/theoncologist.2006-0049